Establishment of Reference Values for Non-HLA Antibodies in Patients With End-stage Renal Disease

참고문헌 (9)

1. Kamburova EG, "Development and validation of a multiplex non-HLA antibody assay for the screening of kidney transplant recipients", Front Immunol, 9, pp.3002~ (2018)
2. Kamburova EG, "Antibodies against ARHGDIB are associated with long-term kidney graft loss", Am J Transplant, 19, pp.3335~3344 (2019)
3. Rampersad C, "Early antibody-mediated kidney transplant rejection associated with anti-vimentin antibodies : a case report", Am J Kidney Dis, 75, pp.138~143 (2020)
4. Kang Hyunhye, "Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience", Annals of Laboratory Medicine, 41(4), pp.429~435 (2021), 대한진단검사의학회[DOI]
5. Miura K, "Chronic active antibody-mediated rejection with linear IgG deposition on glomerular capillaries in a kidney transplant recipient", Nephron, 144(Sl), pp.97~101 (2020)
6. Riesco L, "Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation", Transpl Immunol, 52, pp.53~56 (2019)
7. Rotondi M, "High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients", Transpl Int, 23, pp.465~475 (2010)
8. Zhang X, "Impact of non-human leukocyte antigen-specific antibodies in kidney and heart transplantation", Front Immunol, 8, pp.434~ (2017)
9. Cardinal H, "The emerging importance of non-HLA autoantibodies in kidney transplant complications", J Am Soc Nephrol, 28, pp.400~406 (2017)

관련 논문AI추천